Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$272.9M
18M shares
52-week range
$12.97 – $28.14
15% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
www.natr.comNo one on the platform currently holds NATR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 531,924 | $12.8M |
No one on the platform has traded NATR yet.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $508M | +6.3% | $1.18 | $1.13–$1.22 | 12.9× | 2 |
| 2027 | $531M | +4.6% | $1.32 | $1.22–$1.43 | 11.5× | 2 |
| 2028 | $543M | +2.2% | $0.00 | $0.00–$0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.27 | $0.21 | -22.2% |
| 2026-05-07 | $0.20 | $0.30 | +46.3% |
| 2026-03-10 | $0.18 | $0.30 | +62.2% |
| 2025-11-06 | $0.19 | $0.36 | +89.5% |
| 2025-07-31 | $0.18 | $0.35 | +94.4% |
| 2025-05-06 | $0.17 | $0.25 | +47.1% |
| 2025-03-11 | $0.20 | $-0.02 | -110.0% |
| 2024-11-07 | $0.14 | $0.23 | +64.3% |
| $299M |
| — |
| BRCCBRC Inc. | $0.85 | -1.72% | $269M | — |
| EWCZEuropean Wax Center, Inc. | $5.82 | +0.00% | $319M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$NATR promoted Ruth Perkins to Executive Vice President and Chief Financial Officer, effective Sep 1, with a $575K base salary.
View on StockTwits ↗$NATR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.20 down -31.03% YoY • Reported revenue of $116.98M up 1.95% YoY • Reflecting a stronger U.S. dollar and softness in the China market, Nature's Sunshine now expects full year 2026 net sales of $490 to $500 million and adjusted EBITDA of $48 to $52 million.
View on StockTwits ↗$NATR North America gets a new president as Janine Weber joins the company on Aug. 10.
View on StockTwits ↗$NATR Share Price: $20.82 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $0.59 – $0.73 Target Zone: $1.10 – $1.35 Potential Upside: 75% ROI Time to Expiration: 170 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$NATR Excellent article that nails exactly where NATR stands right now. So if you want to update your NATR knowledge or get acquainted with NATR, this is a must read. https://everyticker.com/quote/NATR/analysis/nature-s-sunshine-digital-autoship-engine-drives-margin-inflection-amid-regulatory-overhang-nasdaq-natr
View on StockTwits ↗$NATR released its Q1 2026 earnings via a press release attached to the 8‑K.
View on StockTwits ↗$NATR Q1 '26 Earnings Results & Recap Nature's Sunshine Products reported consolidated net sales increased 8.5 percent to $122.9 million for the three months ended March 31, 2026. Operating income increased 54.7 percent to $9.55M, and diluted EPS was $0.29.
View on StockTwits ↗$NATR 🚨 🚨 🚨 Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency). GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share. Adjusted EBITDA up 16% to $11.9 million compared to $10.3 million. Full Year 2025 Financial Summary vs. 2024 Net sales were up 5.7% to $480.1 million compared to $454.4 million (up 5.3% in constant currency). GAAP net income attributable to common shareholders of $19.5 million, or $1.06 per diluted share, compared to $7.7 million, or $0.40 per diluted share. Adjusted EBITDA up 21.7% to $49.4 million compared to $40.5 million.
View on StockTwits ↗$NATR Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.23 up 1250.00% YoY • Reported revenue of $123.81M up 4.74% YoY • Nature's Sunshine expects full year 2026 net sales to range between $500M and $515M. Additionally, the company anticipates adjusted EBITDA to range between $50M and $54M for the full year.
View on StockTwits ↗Some other interesting names reporting after the bell besides $ORCL. $AVAV $GRPN $SI $NATR
View on StockTwits ↗$NATR Current Stock Price: $26.69 Contracts to trade: $22.5 NATR Feb 20 2026 Call Entry: $3.50 Exit: $5.24 ROI: 50% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$NATR Nature's Sunshine Products; MLM nutritional supplements; high churn, regulatory scrutiny; China exposure.
View on StockTwits ↗$NATR Current Stock Price: $24.46 Contracts to trade: $20 NATR Feb 20 2026 Call Entry: $4.10 Exit: $5.41 ROI: 32% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$INGR $IFF $NAII $LSF $NATR Is healthy food the next rotation? charts are waking up in clean labels small caps… feels early. full analysis worth a look https://stocksrunner.com/news/2026-01-01-will-the-wellness-trend-lift-healthy-food-stocks-in-2026
View on StockTwits ↗$NATR The investment case increasingly rests on operational credibility rather than long‑range promises. The business must show that scaling does not introduce uncontrolled risk. Unexpected delays could weigh disproportionately on sentiment. Future re‑rating depends on turning narrative into measurable outcomes.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.